Stay updated on Cabozantinib in HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in HR+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study page now displays a recruitment status indicating no longer enrolling participants. New help and navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—are added, alongside a minor label change for Intervention/Treatment and a revision update from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:17:48.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now shows a new revision label, from v3.5.4 to v3.5.5. This signals a metadata update to the page rather than a modification to study details or content.
    Difference
    0.1%
    Check dated 2026-06-08T04:49:18.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a newer document revision. This is a minor metadata update and does not alter the study content visible to users.
    Difference
    0.1%
    Check dated 2026-05-17T10:25:41.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page’s displayed site revision/version was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T18:47:45.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:48:00.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision note updated to v3.5.0, replacing the previous v3.4.3 entry.
    Difference
    0.1%
    Check dated 2026-03-21T01:18:13.000Z thumbnail image

Stay in the know with updates to Cabozantinib in HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.